After the removal of patients with DM , the difference between A@ and A@ BF persisted for OS ( P = @ ) but not for DM ( P = @ ) CONCLUSIONS : These results suggest that patients with rising PSA levels alone have less risk than those with A@ failures ; although DM was the largest contributor of adverse risk to A@ failure , it did not account for all excess risk in A@ failure .